Categories: Research

QBI and Director Krogan’s COVID and infectious disease efforts continue to make waves

Thu Sep 21, 2023
Nevan Krogan receives award.

Research!America President and CEO Mary Woolley (left) with QBI Director Nevan Krogan, PhD (center), and Pfizer Senior Vice President and Head of Vaccine Research and Development Annaliesa Anderson, PhD (right).

QBI publishes breakthrough on COVID-19 variants; Nevan Krogan recognized as trailblazer.

The Kidney Project proves its bioreactor can keep kidney cells alive for at least one week

Fri Sep 1, 2023
bioartificial kidney
Scientists have shown for the first time that kidney cells—housed in an implantable device called a bioreactor—can survive while implanted.

A budding partnership with Korean regulatory science pharmacists

Fri Sep 1, 2023
Giacomini and delegate.
Eric Davila
A delegation from South Korea visited to sign a Memorandum of Understand (MOU) initiating potential collaborations between UCSF and Korean schools of pharmacy.

Structure of dueling proteins points to HIV origins, treatment avenues

Thu Aug 31, 2023

Tracing the structural changes that helped HIV-1 become a human pathogen

Thu Aug 31, 2023

HP1 reshapes nucleosome core to promote phase separation of heterochromatin

Thu Aug 31, 2023

For the first time (in cryo-EM): A3G and Vif structure revealed

Thu Aug 31, 2023

Innovation gets a boost from 2023 Koda-Kimble Seed Awards

Fri Aug 25, 2023
Koda-Kimble
© majedphoto.com

Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy

This ninth year of awards focuses on research advancing health and furthering understanding related to cancer, diabetes, HIV testing, immune response, and more.

Regulatory science at UCSF gets major boost with FDA CERSI renewal

Tue Jul 18, 2023
Giacomini, Hartman, and Gupton sit in front of microphones on a conference stage
Nathan Dang

Kathy Giacomini, PhD, BSPharm (left); Dan Hartman, MD (center); and Frank Gupton, PhD (right), discuss global regulation of medical products at the 2023 CERSI Summit.

The FDA announces the Centers of Excellence in Regulatory Science and Innovation (CERSI) renewals, granting up to $50M for UCSF’s joint effort with Stanford.

Scaling up the bioartificial kidney at UCSF

Mon Jun 12, 2023
Shuvo Roy Headshot
Elisabeth Fall

Shuvo Roy, PhD

On June 12, The Kidney Project was awarded a $1 million Artificial Kidney Prize from KidneyX for advancing its prototype bioartificial kidney toward a full-sized, human scale, with manufacturing and ultimately clinical trials on the horizon.

Pages